Table 2

Clinical characteristics of the study population*

CharacteristicFindings
Age at onset, yr16.7 ± 6.2
Duration of illness, yr14.9 ± 8.0
Current mood state, n
 Euthymic37
 Depressed< 5
 Manic< 5
 Hypomanic< 5
 Mixed< 5
MADRS score
 Control1.7 ± 2.8
 Euthymic4.9 ± 5.6
YMRS score
 Control0.4 ± 1.0
 Euthymic2.3 ± 3.9
Lifetime psychosis, n (%)27 (60.0)
Medication use, n
 Unmedicated5
 Lithium14
 Anticonvulsants20
 Antidepressants16
 Antipsychotics27
 Anxiolytics12
Previous mood episodes
 Depressed16.4 ± 21.8
 Manic7.5 ± 15.9
 Hypomanic13.2 ± 20.1
 Mixed3.4 ± 8.7
 Total40.0 ± 46.9
Lifetime comorbid psychiatric diagnoses, n
 Panic disorder14
 Agoraphobia10
 Social phobia14
 Obsessive–compulsive disorder< 5
 Posttraumatic stress disorder8
 Generalized anxiety disorder< 5
 Anorexia nervosa< 5
 Binge-eating disorder< 5
 Alcohol dependence5
 Alcohol abuse14
 Substance dependence7
 Substance abuse13
  • MADRS = Montgomery–Åsberg Depression Rating Scale; YMRS = Young Mania Rating Scale.

  • * Findings are for the bipolar type I group unless otherwise specified. Control group, n = 60; bipolar type I group, n = 45. Findings that applied to fewer than 5 participants have been suppressed owing to data privacy guidelines.

  • Data are presented as mean ± standard deviation unless otherwise specified.

  • Most participants were on polypharmacy; therefore medication count totals are greater than the sample size (n = 45).